Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. SELLAS Life Sciences Group Inc shares valued at $33,800 were purchased by Wasman Jane on May 30 ’25. At $1.69 per share, Wasman Jane acquired 20,000 shares. The insider’s holdings grew to 30,400 shares worth approximately $45600.0 following the completion of this transaction.
Also, Kalin Katherine Bach purchased 20,000 shares, netting a total of over 36,000 in proceeds. Following the buying of shares at $1.80 each, the insider now holds 41,000 shares.
As published in their initiating research note from Cantor Fitzgerald on July 21, 2021, SELLAS Life Sciences Group Inc [SLS] has been an Overweight and the price target has been revised to $18. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early November. As of April 02, 2018, H.C. Wainwright has initiated its “Buy” rating for SLS. Earlier on March 19, 2018, Maxim Group upgraded its rating. Their new recommendation was “a Buy” for SLS stock which previously was a “a Hold”.
Analyzing SLS Stock Performance
During the last five days, there has been a drop of approximately -6.25%. Over the course of the year, SELLAS Life Sciences Group Inc shares have jumped approximately 44.23%. Shares of the company reached a 52-week high of $2.1200 on 05/27/25 and a 52-week low of $0.8505 on 01/23/25.
Support And Resistance Levels for SELLAS Life Sciences Group Inc (SLS)
According to the 24-hour chart, there is a support level at 1.4700, which, if violated, would cause prices to drop to 1.4400. In the upper region, resistance lies at 1.5400. The next price resistance is at 1.5800. RSI (Relative Strength Index) is 43.66 on the 14-day chart, showing neutral technical sentiment.
